GALWAY, Ireland & SAN DIEGO--(BUSINESS WIRE)--ONK Therapeutics Ltd, an innovative cell therapy company focused on engineered natural killer (NK) cell therapies, today announced it has entered into a ...
Cellular immunotherapy—for example, Chimeric Antigen Receptor (CAR)-T cell therapy—has shown great efficacy in treating various hematologic malignancies. CAR-T therapy has undergone notable changes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback